Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) announced that clinical testing of its lead LIMITX oral abuse deterrent drug candidate using the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE